Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy - Wikidata - wikimedia - TriplyDB

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

http://www.wikidata.org/entity/Q26784039

about

A key role of microRNA-26a in the scar formation after glaucoma filtration surgery.Protection of CTGF Antibody Against Diabetic Nephropathy in Mice Via Reducing Glomerular β-Catenin Expression and Podocyte Epithelial-Mesenchymal Transition.An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.CTGF Contributes to the Development of Posterior Capsule Opacification: an in vitro and in vivo study.

P2860

Q38689911-2B6B0922-B6D3-4056-8833-AD29192E3466 Q40267201-4E92E95A-CDA2-4C71-A72F-7778EB7C86F9 Q47596830-144B3A69-A038-4854-8920-BC43DEEB54C1 Q50063239-1C083774-39DE-4270-85B6-62B2CFB4EB39 Q55078147-64DB15DF-206C-4989-93DF-91EC732BC73D

P2860

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

http://www.wikidata.org/entity/Q26784039

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@ast

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@en

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@nl

type

label

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@ast

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@en

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@nl

prefLabel

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@ast

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@en

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@nl

P1433

Q26784039-D5B5FB99-95C5-4529-BEE0-F89CFB1BE730

P1476

Q26784039-F26CDE24-C75C-4C4B-8B92-40BEFFBCB515

P2093

Q26784039-60197424-B0CB-402B-BA4B-7B170BE0EA32

Q26784039-93329921-BE4E-4B09-8D01-897C5F3ACF7C

Q26784039-C381A909-A2BF-41FD-97EC-5D8BABD4FEF8

Q26784039-D6884750-E03B-4D0D-AB6D-65738D39C659

Q26784039-E68C543F-B996-4212-B712-06ECE52D5184

P275

Q26784039-0BBFAD71-65FA-4F3C-8F2B-106725F09C80

P2860

Q26784039-0047898E-0282-4049-B235-49598D6BF165

Q26784039-0334ECE9-AF3F-4372-9FEC-24AE89AB914D

Q26784039-03C627F8-9377-4321-B096-7B1356E3976C

Q26784039-08D66C79-CF1C-4952-9577-3F1DCA96E277

Q26784039-0BDC85AB-63C6-49E0-8DE7-27EB41FCFD9D

Q26784039-12EE01FE-B5A0-4F9C-9FBF-625F8DE1DCB0

Q26784039-13A67ABB-148F-4261-AB70-9BF427454495

Q26784039-184B85B4-FD76-4375-8549-04E045D65D76

Q26784039-1A470851-B829-4BB8-9E88-C0391F950D42

Q26784039-1FF9C4E5-5697-4E72-95DE-9A4A21438BC6

P304

Q26784039-2160C3D3-6086-43E1-BAA1-FEA0C94F5F1F

P31

Q26784039-414F28CD-96BD-4F4A-954D-07F1DA164889

Q26784039-9F61BD88-C43E-43E0-B5EC-A15F91E58768

P356

Q26784039-F1CCB426-F578-4A68-9883-409E0AED1A20

P407

Q26784039-1D985869-8940-4933-A6E9-0DD0FFCBDAE8

P478

Q26784039-250C074C-B08B-47BC-A0C9-4A03B447AB26

P5008

Q26784039-E48D4460-BC63-44C6-95B9-C14617FC6C87

P577

Q26784039-715A520B-1605-4BCC-B89A-E3DCCD35E451

P5875

Q26784039-E907061D-E0FC-48F2-B070-AD45BFD6C6EA

P698

Q26784039-29EEEDE3-CE7B-457B-A823-17836AC4868C

P921

Q26784039-06D47C1C-3593-4C0F-A43A-DD7AA04A9322

Q26784039-2A5D7CFB-A62A-4A25-B62A-CF10018774A2

Q26784039-7C433F46-BE47-4199-B829-EA879382C54F

Q26784039-E38290E6-259E-4E7B-8122-4AC72E12CB6F

P932

Q26784039-9369692B-9CA3-4018-8CE5-366A5AD5A855

P356

P1433

Journal of Diabetes Research

P1476

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy

@en

P2093

Bing Li

http://www.w3.org/2001/XMLSchema#string

Chunguang Li

http://www.w3.org/2001/XMLSchema#string

Lining Miao

http://www.w3.org/2001/XMLSchema#string

Songyan Wang

http://www.w3.org/2001/XMLSchema#string

Wenpeng Cui

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells

Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3

RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.

Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.

Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria

Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways.

(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.

P304

962383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/962383

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282480998

http://www.w3.org/2001/XMLSchema#string

P698

26421309

http://www.w3.org/2001/XMLSchema#string

P921

fibrous protein

genitourinary system

P932

4572424

http://www.w3.org/2001/XMLSchema#string